- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.12.24 | Candid partners with EpimAb to develop T-cell engager candidates | ||
| 16.12.24 | Sanofi's multiple sclerosis therapy gains breakthrough therapy status from FDA | ||
| 13.12.24 | Tanner-Agenus partner for expanded access to immunotherapies for cancer patients | ||
| 12.12.24 | ProQR expands partnership with RSRT to advance Rett Syndrome therapy | ||
| 11.12.24 | Orthogon secures funding to boost BK virus treatments for transplant patients | ||
| 10.12.24 | FDA accepts Crinetics Pharmaceuticals' NDA for acromegaly treatment therapy | ||
| 09.12.24 | Torii submits NDA for molluscum contagiosum treatment therapy in Japan | ||
| 06.12.24 | MindMed receives innovation passport for GAD therapy from UK MHRA | ||
| 05.12.24 | Theratechnologies to license Ionis' RNA-targeted therapies in Canada | ||
| 04.12.24 | Gilead and Tubulis sign ADC development deal for cancer treatment | ||
| 03.12.24 | Japan MHLW grants orphan drug status to Renalys' sparsentan for IgAN treatment | ||
| 02.12.24 | Hong Kong regulator accepts Everest's ulcerative colitis therapy NDA | ||
| 29.11.24 | Dr. Reddy's Laboratories introduces Toripalimab in India for nasopharyngeal carcinoma | ||
| 28.11.24 | China's NMPA grants marketing approval to Kelun-Biotech's sac-TMT for TNBC treatment | ||
| 27.11.24 | Valneva submits application seeking FDA approval for IXCHIQ for adolescent use | ||
| 26.11.24 | FDA accepts Alnylam's vutrisiran sNDA to treat ATTR-CM | ||
| 25.11.24 | FDA approves StemCyte's cord blood stem cell therapy BLA | ||
| 22.11.24 | Dyadic receives grant from Gates Foundation for RSV antibody development | ||
| 21.11.24 | Laekna partners with Lilly to develop obesity therapy | ||
| 20.11.24 | FDA grants ODD to Ractigen Therapeutics' RAG-21 for ALS treatment | ||
| 19.11.24 | Arrowhead Pharmaceuticals submits plozasiran NDA to treat FCS | ||
| 18.11.24 | Numab Therapeutics and Kaken Pharmaceutical collaborate to develop ND081 | ||
| 15.11.24 | FDA to review Sanofi, Regeneron's Dupixent sBLA for CSU | ||
| 14.11.24 | Asha Therapeutics secures grant for ALS therapeutic development | ||
| 13.11.24 | AstraZeneca and Daiichi Sankyo submit BLA to FDA for lung cancer treatment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
